ETHEMA HEALTH PE Ratio 2010-2024 | GRST
Current and historical p/e ratio for ETHEMA HEALTH (GRST) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ETHEMA HEALTH PE ratio as of May 23, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ETHEMA HEALTH PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-23 | 0.00 | 0.00 | |
| 2024-09-30 | 0.00 | 0 | 0.00 |
| 2024-06-30 | 0.00 | 0 | 0.00 |
| 2024-03-31 | 0.00 | 0 | 0.00 |
| 2023-12-31 | 0.00 | 0 | 0.00 |
| 2023-09-30 | 0.00 | 0 | 0.00 |
| 2023-06-30 | 0.00 | 0 | 0.00 |
| 2023-03-31 | 0.00 | 0 | 0.00 |
| 2022-12-31 | 0.00 | 0 | 0.00 |
| 2022-09-30 | 0.00 | 0 | 0.00 |
| 2022-06-30 | 0.00 | 0 | 0.00 |
| 2022-03-31 | 0.00 | 0 | 0.00 |
| 2021-12-31 | 0.00 | 0 | 0.00 |
| 2021-09-30 | 0.00 | $0.01 | 0.22 |
| 2021-06-30 | 0.00 | 0 | 0.00 |
| 2021-03-31 | 0.01 | 0 | 0.00 |
| 2020-12-31 | 0.00 | $-0.01 | 0.00 |
| 2020-09-30 | 0.00 | $-0.09 | 0.00 |
| 2020-06-30 | 0.00 | $-0.08 | 0.00 |
| 2020-03-31 | 0.00 | $-0.09 | 0.00 |
| 2019-12-31 | 0.00 | $-0.10 | 0.00 |
| 2019-09-30 | 0.05 | $-0.04 | 0.00 |
| 2019-06-30 | 0.07 | $-0.06 | 0.00 |
| 2019-03-31 | 0.08 | $-0.07 | 0.00 |
| 2018-12-31 | 0.08 | $-0.06 | 0.00 |
| 2018-09-30 | 0.08 | $-0.05 | 0.00 |
| 2018-06-30 | 0.08 | $-0.03 | 0.00 |
| 2018-03-31 | 0.07 | 0 | 0.00 |
| 2017-12-31 | 0.06 | $0.08 | 0.75 |
| 2017-09-30 | 0.06 | $0.05 | 1.10 |
| 2017-06-30 | 0.06 | $0.05 | 1.18 |
| 2017-03-31 | 0.03 | $0.04 | 0.83 |
| 2016-12-31 | 0.02 | $-0.03 | 0.00 |
| 2016-09-30 | 0.03 | $-0.01 | 0.00 |
| 2016-06-30 | 0.04 | $-0.01 | 0.00 |
| 2016-03-31 | 0.03 | $-0.01 | 0.00 |
| 2015-12-31 | 0.07 | $-0.02 | 0.00 |
| 2015-09-30 | 0.03 | $-0.01 | 0.00 |
| 2015-06-30 | 0.03 | $-0.01 | 0.00 |
| 2015-03-31 | 0.04 | $-0.01 | 0.00 |
| 2014-12-31 | 0.08 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.003B | $0.005B |
| Ethema Health Corp offers addiction and mental health rehabilitation treatments for residents. The company has developed a unique style of treatment that has demonstrated much success with in-patient treatment for adults. It operates primarily in Delray Beach, Florida, located between Palm Beach and Miami. Ethema Health Corp, formerly known as GreeneStone Healthcare Corporation, is based in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $132.070B | 24.77 |
| Elevance Health (ELV) | United States | $84.109B | 10.85 |
| CVS Health (CVS) | United States | $76.951B | 9.56 |
| Cencora (COR) | United States | $56.664B | 19.71 |
| DiDi Global (DIDIY) | China | $22.591B | 34.29 |
| Natera (NTRA) | United States | $20.935B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.529B | 0.00 |
| Solventum (SOLV) | United States | $12.251B | 12.97 |
| CochLear (CHEOY) | Australia | $11.298B | 0.00 |
| Revvity (RVTY) | United States | $10.529B | 18.12 |
| ICON (ICLR) | Ireland | $10.336B | 9.61 |
| Viatris (VTRS) | United States | $9.730B | 3.34 |
| Doximity (DOCS) | United States | $9.525B | 44.37 |
| Avantor (AVTR) | United States | $8.647B | 12.56 |
| HealthEquity (HQY) | United States | $8.564B | 42.13 |
| Medpace Holdings (MEDP) | United States | $8.476B | 22.51 |
| Sonic Healthcare (SKHHY) | Australia | $8.176B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.716B | 13.16 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.048B | 37.47 |
| Bausch + Lomb (BLCO) | Canada | $3.990B | 23.52 |
| Sotera Health (SHC) | United States | $3.452B | 19.61 |
| Surgery Partners (SGRY) | United States | $2.922B | 38.00 |
| Alignment Healthcare (ALHC) | United States | $2.865B | 0.00 |
| Concentras Parent (CON) | United States | $2.710B | 15.66 |
| Organon (OGN) | United States | $2.259B | 2.40 |
| Ardent Health Partners (ARDT) | United States | $2.091B | 8.91 |
| GeneDx Holdings (WGS) | United States | $2.043B | 78.68 |
| Premier (PINC) | United States | $1.899B | 14.41 |
| Progyny (PGNY) | United States | $1.759B | 38.72 |
| PACS (PACS) | United States | $1.497B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.336B | 26.71 |
| Teladoc Health (TDOC) | United States | $1.195B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.165B | 8.86 |
| Establishment Labs Holdings (ESTA) | $1.059B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.944B | 14.74 |
| Agilon Health (AGL) | United States | $0.919B | 0.00 |
| Nutex Health (NUTX) | United States | $0.890B | 13.45 |
| AMN Healthcare Services Inc (AMN) | United States | $0.795B | 7.44 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.626B | 4.22 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| LifeMD (LFMD) | United States | $0.524B | 0.00 |
| Enhabit (EHAB) | United States | $0.518B | 42.58 |
| Auna S.A (AUNA) | Luxembourg | $0.492B | 11.08 |
| SBC Medicals (SBC) | United States | $0.471B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.462B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.405B | 0.00 |
| Oncology Institute (TOI) | United States | $0.228B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.215B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.137B | 22.33 |
| OncoCyte (OCX) | United States | $0.096B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.066B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Biodesix (BDSX) | United States | $0.050B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.025B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |